• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙二胺对药物溶液中天冬胰岛素化学降解的影响。

Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.

作者信息

Poulsen Christian, Jacobsen Dorte, Palm Lisbeth

机构信息

Pharmaceutics, Diabetes Department, Novo Nordisk A/S, Novo Alle, room 6B1.58.1, 2880 Bagsvaerd, Denmark.

出版信息

Pharm Res. 2008 Nov;25(11):2534-44. doi: 10.1007/s11095-008-9670-8. Epub 2008 Jul 8.

DOI:10.1007/s11095-008-9670-8
PMID:18607693
Abstract

PURPOSE

To examine the effect of different amine compounds on the chemical degradation of insulin aspart at pharmaceutical formulation conditions.

METHODS

Insulin aspart preparations containing amine compounds or phosphate (reference) were prepared and the chemical degradation was assessed following storage at 37 degrees C using chromatographic techniques. Ethylenediamine was examined at multiple concentrations and the resulting insulin-ethylenediamine derivates were structurally characterized using matrix assisted laser desorption ionization time-of-flight mass spectroscopy. The effects on ethylenediamine when omitting glycerol or phenolic compounds from the formulations were investigated.

RESULTS

Ethylenediamine was superior in terms of reducing formation of high molecular weight protein and insulin aspart related impurities compared to the other amine compounds and phosphate. Monotransamidation of insulin aspart in the presence of ethylenediamine was observed at all of the six possible Asn/Gln residues with Asn(A21) having the highest propensity to react with ethylenediamine. Data from formulations studies suggests a dual mechanism of ethylenediamine and a mandatory presence of phenolic compounds to obtain the effect.

CONCLUSIONS

The formation of high molecular weight protein and insulin aspart related impurities was reduced by ethylenediamine in a concentration dependant manner.

摘要

目的

考察不同胺类化合物在药物制剂条件下对门冬胰岛素化学降解的影响。

方法

制备含胺类化合物或磷酸盐(对照)的门冬胰岛素制剂,并使用色谱技术评估在37℃储存后的化学降解情况。对多种浓度的乙二胺进行考察,并使用基质辅助激光解吸电离飞行时间质谱对所得的胰岛素-乙二胺衍生物进行结构表征。研究了制剂中省略甘油或酚类化合物时对乙二胺的影响。

结果

与其他胺类化合物和磷酸盐相比,乙二胺在减少高分子量蛋白质和门冬胰岛素相关杂质的形成方面表现更优。在乙二胺存在下,观察到门冬胰岛素在所有六个可能的天冬酰胺/谷氨酰胺残基处发生单酰胺化,其中天冬酰胺(A21)与乙二胺反应的倾向最高。制剂研究数据表明乙二胺的作用机制具有双重性,且酚类化合物的存在是获得该效果的必要条件。

结论

乙二胺以浓度依赖的方式减少了高分子量蛋白质和门冬胰岛素相关杂质的形成。

相似文献

1
Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.乙二胺对药物溶液中天冬胰岛素化学降解的影响。
Pharm Res. 2008 Nov;25(11):2534-44. doi: 10.1007/s11095-008-9670-8. Epub 2008 Jul 8.
2
Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.苯酚和间甲酚消耗对生理温度下胰岛素类似物稳定性的影响。
J Pharm Sci. 2014 Aug;103(8):2255-67. doi: 10.1002/jps.24039. Epub 2014 Jun 6.
3
Insulin aspart (AspB28 human insulin) derivatives formed in pharmaceutical solutions.
Pharm Res. 2002 May;19(5):621-8. doi: 10.1023/a:1015302012070.
4
Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart.使长效胰岛素德谷与速效胰岛素门冬共配制的物理化学性质研究。
Pharm Res. 2015 Jul;32(7):2250-8. doi: 10.1007/s11095-014-1614-x. Epub 2015 Jan 8.
5
Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.速效和人胰岛素:药物制剂稀释时的六聚体解离动力学。
Pharm Res. 2017 Nov;34(11):2270-2286. doi: 10.1007/s11095-017-2233-0. Epub 2017 Jul 31.
6
In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump.使用美敦力508胰岛素泵在模拟持续皮下胰岛素输注中门冬胰岛素的体外稳定性
Diabetes Technol Ther. 2007 Feb;9(1):75-9. doi: 10.1089/dia.2006.0041.
7
Insulin aspart: a new rapid-acting insulin analog.门冬胰岛素:一种新型速效胰岛素类似物。
Ann Pharmacother. 2000 Dec;34(12):1423-31. doi: 10.1345/aph.19414.
8
Intrinsic fibrillation of fast-acting insulin analogs.速效胰岛素类似物的内在纤颤。
J Diabetes Sci Technol. 2012 Mar 1;6(2):265-76. doi: 10.1177/193229681200600209.
9
Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.人胰岛素中性制剂储存过程中形成的高分子量产物的纯化与鉴定
Pharm Res. 2015 Jun;32(6):2072-85. doi: 10.1007/s11095-014-1600-3. Epub 2015 Jan 14.
10
Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps.胰岛素泵模拟使用过程中门冬胰岛素和赖脯胰岛素的体外稳定性比较。
Diabetes Technol Ther. 2007 Dec;9(6):517-21. doi: 10.1089/dia.2007.0233.

引用本文的文献

1
In vitro assessment of the influence of intravenous extension set materials on insulin aspart drug delivery.静脉延长套件材料对门冬胰岛素给药影响的体外评估。
PLoS One. 2018 Aug 16;13(8):e0201623. doi: 10.1371/journal.pone.0201623. eCollection 2018.
2
Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.人胰岛素中性制剂储存过程中形成的高分子量产物的纯化与鉴定
Pharm Res. 2015 Jun;32(6):2072-85. doi: 10.1007/s11095-014-1600-3. Epub 2015 Jan 14.

本文引用的文献

1
Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer.胰岛素的化学和热稳定性:锌及配体与胰岛素锌六聚体结合的影响
Pharm Res. 2006 Nov;23(11):2611-20. doi: 10.1007/s11095-006-9098-y. Epub 2006 Sep 13.
2
Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review.锌-配体相互作用调节胰岛素六聚体的组装与稳定性——综述
Biometals. 2005 Aug;18(4):295-303. doi: 10.1007/s10534-005-3685-y.
3
Accelerated aging: prediction of chemical stability of pharmaceuticals.
加速老化:药物化学稳定性的预测
Int J Pharm. 2005 Apr 11;293(1-2):101-25. doi: 10.1016/j.ijpharm.2004.12.013.
4
Insulin aspart (AspB28 human insulin) derivatives formed in pharmaceutical solutions.
Pharm Res. 2002 May;19(5):621-8. doi: 10.1023/a:1015302012070.
5
R6 hexameric insulin complexed with m-cresol or resorcinol.与间甲酚或间苯二酚复合的R6六聚体胰岛素。
Acta Crystallogr D Biol Crystallogr. 2000 Dec;56(Pt 12):1541-8. doi: 10.1107/s0907444900012749.
6
Instability, stabilization, and formulation of liquid protein pharmaceuticals.液体蛋白质药物的不稳定性、稳定性及制剂
Int J Pharm. 1999 Aug 20;185(2):129-88. doi: 10.1016/s0378-5173(99)00152-0.
7
A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.应激状态下中性鱼精蛋白胰岛素制剂中一种新型蛋白质交联反应。
J Pharm Sci. 1999 Mar;88(3):331-6. doi: 10.1021/js9802603.
8
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues.苯酚和间甲酚在胰岛素六聚体中的相互作用及其对B28脯氨酸→天冬氨酸胰岛素类似物缔合特性的影响。
Biochemistry. 1998 Aug 18;37(33):11516-23. doi: 10.1021/bi980807s.
9
Immunogenicity and allergenic potential of animal and human insulins.动物胰岛素和人胰岛素的免疫原性及致敏潜力。
Diabetes Care. 1993 Dec;16 Suppl 3:155-65. doi: 10.2337/diacare.16.3.155.
10
The role of intramolecular nucleophilic catalysis and the effects of self-association on the deamidation of human insulin at low pH.分子内亲核催化的作用以及自缔合对低pH值下人胰岛素脱酰胺作用的影响。
Pharm Res. 1994 Jun;11(6):784-93. doi: 10.1023/a:1018909220255.